Subscribe
Webinars
White Papers
Buyer's Guide
PhotonicsNXT
Get Published!
Lasers/Sources
Detectors/Imaging
Optics
Bio & Life Sciences
Laser Processing
Test/Measurement
Science & Research
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
LFW Photonics Market Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Champions Oncology, Inc.
Champions Oncology Reports Quarterly Revenue of $12.9 Million
July 21, 2022
From
Champions Oncology, Inc.
Via
AccessWire
Tickers
CSBR
Champions Oncology to Announce Fourth Quarter Financial Results on Thursday, July 21, 2022
July 14, 2022
From
Champions Oncology, Inc.
Via
AccessWire
Tickers
CSBR
Champions Oncology Announces a Partnership with Cyclica to Develop Small Molecule Therapeutics
May 31, 2022
From
Champions Oncology, Inc.
Via
AccessWire
Tickers
CSBR
Champions Oncology Announces its Lumin Bioinformatics Platform Selected as a Finalist for the 'Best in Show' Competition at Bio-IT World Conference & Expo
May 03, 2022
From
Champions Oncology, Inc.
Via
AccessWire
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Tickers
CSBR
Champions Oncology Reports Record Quarterly Revenue of $13.2 Million Reported Adjusted EBITDA of $1.5 million
March 15, 2022
From
Champions Oncology, Inc.
Via
AccessWire
Tickers
CSBR
Champions Oncology to Announce Third Quarter Financial Results on Tuesday, March 15, 2022
March 11, 2022
From
Champions Oncology, Inc.
Via
AccessWire
Tickers
CSBR
Champions Oncology Announces a Partnership with GigaMune to Discover Novel Tumor-Reactive T Cell Receptors
February 15, 2022
From
Champions Oncology, Inc.
Via
AccessWire
Tickers
CSBR
Champions Oncology Announces a Partnership with Fannin Innovation to Jointly Develop Therapeutic Raptamer Drug Conjugates
January 20, 2022
From
Champions Oncology, Inc.
Via
AccessWire
Tickers
CSBR
Champions Oncology Announces a Partnership with Alloy Therapeutics to Develop Therapeutic Monoclonal Antibodies for Use in ADC Programs
January 04, 2022
From
Champions Oncology, Inc.
Via
AccessWire
Tickers
CSBR
Champions Oncology Reports Record Quarterly Revenue of $11.8 Million
December 13, 2021
From
Champions Oncology, Inc.
Via
AccessWire
Tickers
CSBR
Champions Oncology to Announce Second Quarter Financial Results on Monday, December 13, 2021
December 06, 2021
From
Champions Oncology, Inc.
Via
AccessWire
Tickers
CSBR
Champions Oncology Expands Global Biomarker Capabilities with Opening of European Laboratory at OpenZone Life Sciences Campus
October 20, 2021
From
Champions Oncology, Inc.
Via
AccessWire
Tickers
CSBR
Champions Oncology Reports Record Quarterly Revenue of $11.3 Million
September 13, 2021
From
Champions Oncology, Inc.
Via
AccessWire
Topics
Earnings
Exposures
Financial
Tickers
CSBR
Champions Oncology to Announce First Quarter Financial Results on Monday, September 13, 2021
September 02, 2021
From
Champions Oncology, Inc.
Via
AccessWire
Tickers
CSBR
Champions Oncology Announces an Expanded Corporate Strategy to Include Drug Discovery and Development
July 26, 2021
From
Champions Oncology, Inc.
Via
AccessWire
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Tickers
CSBR
Champions Oncology Reports Quarterly Revenue of $10.6 Million
July 22, 2021
From
Champions Oncology, Inc.
Via
AccessWire
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Tickers
CSBR
Champions Oncology to Announce Fourth Quarter Financial Results on Thursday, July 22, 2021
July 14, 2021
From
Champions Oncology, Inc.
Via
AccessWire
Tickers
CSBR
Champions Oncology and BGI Americas Announce a Strategic Partnership to Provide Mass Spectrometry Proteomics, Metabolomics, and Multi-Omic Data Analysis Solutions
June 15, 2021
From
Champions Oncology, Inc.
Via
AccessWire
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Tickers
CSBR
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.